David T. Vistica

New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations

Medicine, Oncology, Pharmacology +10

Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines

Anne Monks, Dominic A. Scudiero, Philip Skehan et al. · JNCI Journal of the National Cancer Institute · 1991 · 3.3K citations

Medicine, Oncology, Pharmacology +11

Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.

David T. Vistica, Philip Skehan, Dominic A. Scudiero et al. · PubMed · 1991 · 748 citations

Medicine, Biochemistry, Pharmacology +15

Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.

J A Green, David T. Vistica, Robert C. Young et al. · PubMed · 1984 · 236 citations

Medicine, Oncology, Pharmacology +15

Reduction in glutathione content of L-PAM resistant L1210 cells confers drug sensitivity

Kayoko Suzukake, Barbara J. Petro, David T. Vistica · Biochemical Pharmacology · 1982 · 203 citations

Medicine, Pharmacology, Cellular Pharmacology +6